Showing 1 of 1 recruiting trials for “spastic-paraplegia-facial-cutaneous-lesions-syndrome”
Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls.
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →